908 Devices Inc. announced the launch of MAVEN, a device for on-line monitoring and control of glucose and lactate in cell culture and fermentation processes. MAVEN empowers biopharma companies to make timely decisions based on highly sensitive, real-time measurements. Taking measurements as frequently as every two minutes, MAVEN operates without having to manually draw samples out of the bioreactor due to its novel aseptic sampling approach.

This improves process understanding, saves operator time and reduces the risk of process contamination--which in turn accelerates development workflows. For biopharmaceutical process development scientists who seek to optimize cell culture and fermentation processes to improve product yield, quality, efficacy and safety, MAVEN provides highly precise, on-line monitoring of glucose and lactate without any loss of bioreactor volume. This enables real-time control of substrate feeding to maintain optimal nutrient and metabolite concentrations, even at very low levels.

MAVEN is used in concert with the company's REBEL device, an at-line cell culture media analyzer that quantitates over 30 additional key media nutrients in less than 10 minutes.